HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$9.16
Day range
$9.22 - $9.77
Year range
$6.50 - $18.98
Market cap
1.04B USD
Avg Volume
773.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 160.00M | 310.26% |
Operating expense | 29.00M | -3.33% |
Net income | 0.00 | 100.00% |
Net profit margin | 0.00 | 100.00% |
Earnings per share | 0.00 | 100.00% |
EBITDA | -6.00M | 94.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 911.00M | -5.99% |
Total assets | 1.08B | -9.36% |
Total liabilities | 526.00M | -4.54% |
Total equity | 549.00M | — |
Shares outstanding | 106.43M | — |
Price to book | 1.78 | — |
Return on assets | -1.79% | — |
Return on capital | -3.10% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 0.00 | 100.00% |
Cash from operations | -133.00M | -41.49% |
Cash from investing | 137.00M | 117.46% |
Cash from financing | 52.00M | 2,500.00% |
Net change in cash | 56.00M | 293.10% |
Free cash flow | 27.75M | 183.46% |
About
Founded
2015
Website
Employees
627
